Thickening Silica as a Fluoride Carrier for Customized Delivery and Slow Release
The oral care composition that adsorbs and slowly releases fluoride on the enamel, the fluoride delivery problem is solved, and the resistance of the enamel and the effect of caries prevention and treatment are improved.
Patent Information
- Application Number
- CN202080084698.3
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Priority Date
- 2019-12-12
- Filing Date
- 2020-12-11
- Publication Date
- 2024-11-12
- Estimated Expiration
- 2040-12-11
AI Technical Summary
The prior art is difficult to effectively deliver fluoride to the surface of enamel, resulting in poor dental caries prevention and treatment effect.
Fluorine is ensured by adsorption of fluoride on silica and bonding at low pH conditions using oral care compositions containing thickening silica and fluoride sources. Chemicals can effectively reach tooth enamel.
The slow release and effective delivery of fluoride is achieved, the resistance of enamel is enhanced, the formation of caries is reduced, the remineralization of teeth is promoted, and the formation of oral microbial biofilms is reduced.
Smart Images

Figure CN114760975B_ABST
Abstract
Description
[0001] CROSS-REFERENCE TO RELATED APPLICATIONS
[0002] This application claims the benefit of and priority to U.S. Provisional Application No. 62 / 947,265, filed on December 12, 2019. Background Art
[0003] Fluoride is one of the agents commonly used to prevent dental caries. Fluoride can greatly help dental health by strengthening tooth enamel, making it more resistant to tooth caries. Fluoride also helps to remineralize weakened tooth enamel and reverse the early signs of tooth caries. Many oral care products, such as toothpaste, mouthwash and professional dental treatment products, contain fluoride. Fluoride must be effectively delivered to the enamel surface to be effective. The selection of formulation ingredients is important in determining whether fluoride is effectively delivered to the enamel surface. There is still a need in the art for an oral care composition with an improved way of delivering fluoride to the enamel surface. Summary of the invention
[0004] In one aspect, the present invention provides an oral care composition comprising an orally acceptable carrier, thickening silica, and a fluoride ion source, wherein fluoride (fluoride ion) is adsorbed onto the thickening silica, wherein the thickening silica has a particle size distribution (D95) of less than or equal to 7 μm and a particle size distribution (D95) of greater than or equal to 150 μm. 2 / g BET surface area, and wherein the pH of the composition is less than 5.5. In some embodiments, the thickening silica may have a BET surface area greater than or equal to 175 m 2 / g, greater than or equal to 200m 2 / g, or greater than or equal to 250m 2 / g BET surface area. In some embodiments, the thickening silica may have an oil adsorption rate greater than or equal to about 200 mL / 100 g, about 240 mL / 100 g, or about 250 mL / 100 g. In some embodiments, the thickening silica may have an average particle size of about 3 μm to about 5 μm, about 3 μm to about 4 μm, or about 3.5 μm. In a preferred embodiment, the thickening silica is Tixosil 331.
[0005] In some embodiments, the thickening silica can be present in an amount of about 1 wt % to about 20 wt %, about 1 wt % to about 10 wt %, about 2 wt % to about 10 wt %, about 4 wt % to about 6 wt %, about 4.5 wt % to about 5.5 wt %, about 4.8 wt % to about 5.2 wt %, or about 5.0 wt %, based on the total weight of the oral care composition.
[0006] In some embodiments, the fluoride ion source can be selected from sodium fluoride, stannous fluoride, potassium fluoride, sodium monofluorophosphate, sodium fluorosilicate, ammonium fluorosilicate, amine fluoride (e.g., N'-octadecyltrimethylenediamine-N,N,N'-tri(2-ethanol)-dihydrofluoride), ammonium fluoride, titanium fluoride, hexafluorosulfate, and combinations thereof. In a preferred embodiment, the fluoride ion source is sodium fluoride.
[0007] In some embodiments, the amount of fluoride ion source is sufficient to provide 25 ppm to 5000 ppm, typically at least 500 ppm, such as 500 to 2000 ppm, such as 1000 ppm to 1600 ppm, such as 1450 ppm of fluoride ion.
[0008] In some embodiments, the amount of fluoride adsorbed on the thickening silica is 1% to 20% by weight of the thickening silica. In some embodiments, the amount of fluoride adsorbed on the thickening silica is 2% to 20% by weight of the thickening silica, such as 5% to 20%, 10% to 20%, 15% to 20%, 16% to 20%, 17% to 20%, 18% to 20%, or 18% to 19%.
[0009] In another aspect, the present invention provides a method comprising applying an effective amount of an oral care composition as disclosed herein to the oral cavity of a subject in need thereof, for example by brushing, to: (i) reduce or inhibit the formation of caries, (ii) reduce, repair or inhibit pre-caries lesions of tooth enamel, (iii) reduce or inhibit tooth demineralization and promote tooth remineralization, (iv) reduce tooth sensitivity, (v) reduce or inhibit gingivitis, (vi) promote the healing of ulcers or wounds in the oral cavity, (vii) reduce the level of acid-producing bacteria, (viii) reduce or inhibit the formation of microbial biofilms in the oral cavity, (ix) reduce or inhibit the formation of plaque in the oral cavity, (x) promote systemic health or (xi) clean the teeth and oral cavity.
[0010] In another aspect, the present invention provides a method for preparing a fluoride-loaded thickening silica, comprising mixing a thickening silica and a fluoride ion source in an aqueous solution (e.g., water) at a pH below 5.5, e.g., 3.5 to 5.5, 3.5 to 5.0, 3.5 to 4.5, 4.0 to 5.0, 4.0 to 4.5, 3.5 to 4.0, 3.8 to 4.2, or about 4.0, wherein the thickening silica has a particle size distribution (D95) of less than or equal to 7 μm and a particle size distribution (D95) of greater than or equal to 150 μm. 2 In some embodiments, the thickening silica may have a BET surface area greater than or equal to 175 m 2 / g, greater than or equal to 200m 2 / g, or greater than or equal to 250m2 / g BET surface area. In some embodiments, the thickening silica may have an oil adsorption rate greater than or equal to about 200 mL / 100 g, about 240 mL / 100 g, or about 250 mL / 100 g. In some embodiments, the thickening silica may have an average particle size of about 3 μm to about 5 μm, about 3 μm to about 4 μm, or about 3.5 μm. In a preferred embodiment, the thickening silica is Tixosil 331.
[0011] In another aspect, the present invention provides an oral care composition comprising a thickening silica loaded with fluoride prepared by any of the methods disclosed herein. The fluoride adsorbed on the thickening silica is released at a pH of 8.0.
[0012] Other applicable fields of the present disclosure will become apparent from the detailed description provided hereinafter.It should be understood that the detailed description and specific examples, although indicating some typical aspects of the present disclosure, are intended for illustrative purposes only and are not intended to limit the scope of the present disclosure. BRIEF DESCRIPTION OF THE DRAWINGS
[0013] The present invention will be more fully understood from the detailed description and accompanying drawings.
[0014] Figure 1 is a graph showing the release of fluoride from silica fluoride as the pH of the solution is changed.
[0015] Figure 2 is a graph of fluoride release from silica fluoride over time after the solution pH was changed from 4 to 8 in one step. DETAILED DESCRIPTION
[0016] The following description of various exemplary aspects is merely exemplary in nature and is in no way intended to limit the present disclosure, its application, or uses.
[0017] The range used throughout the text is used as a shorthand way of expressing each value within the range. Any value within the range can be selected as the endpoint of the range. In addition, all references cited herein are incorporated by reference in their entirety. In the event that a definition in the present disclosure conflicts with the definition of the cited reference, the present disclosure shall prevail.
[0018] Unless otherwise indicated, all percentages and amounts expressed herein and elsewhere in this specification are to be understood as referring to percentages by weight. The amounts given are based on the effective weight of the material.
[0019] The present invention relates to the use of thickening silica having a particle size distribution (D95) of less than or equal to 7 μm and a particle size distribution (D95) of greater than or equal to 150 μm.2 / g of BET surface area, the thickening silica is used as a fluoride carrier for customized delivery of fluoride to tooth texture and in-situ slow release of fluoride. It has been found that when thickening silica and fluoride are mixed in aqueous solution at low pH (e.g., 4.0), most fluorides can be combined with thickening silica (e.g., Tixosil 331). It has been further found that by changing the pH to 8, the adsorption process can be easily reversed, and the release of fluoride is a slow process, i.e., by changing the pH of the solution from 4.0 to 8.0, the complete release of fluoride requires about 400s, i.e., more than 3-4 times the normal brushing time. These findings are interesting, because most fluorides can be adsorbed on the thickening silica in the oral care composition of low pH. However, when in use, after reaching equilibrium at the physiological pH of about 7 to 8 in the oral cavity, fluoride can be released in the mouth. Combined with the fact that Tixosil 331 shown in WO 2019 / 120467 can adhere to dentin and block dentin tubules, and thus effectively reduce tooth sensitivity, thickening silica loaded with fluoride can be used to reduce tooth allergic reactions and effectively deliver fluoride to dentin at the same time. Fluoride is slowly released in the mouth so that thickening silica reaches and adheres to dentin before releasing fluoride.
[0020] In one aspect, the present invention provides an oral care composition (composition 1.0), such as a toothpaste or a gel, comprising an orally acceptable carrier, thickening silica, and a fluoride ion source, wherein the thickening silica has a particle size distribution (D95) of less than or equal to 7 μm and a particle size distribution (D95) of greater than or equal to 150 μm. 2 / g of BET surface area, and wherein the pH of the composition is below 5.5.
[0021] For example, the present invention includes:
[0022] 1.1. Composition 1.0, wherein fluoride (fluoride ion) is adsorbed onto thickening silica.
[0023] 1.2. Any of the foregoing compositions, wherein the thickening silica has a thickness greater than or equal to 175 m 2 / g, greater than or equal to 200m 2 / g, or greater than or equal to 250m 2 / g of BET surface area.
[0024] 1.3. Any of the preceding compositions, wherein the thickening silica has an average particle size of about 3 μm to about 5 μm, about 3 μm to about 4 μm, or about 3.5 μm.
[0025] 1.4. Any of the preceding compositions, wherein the thickening silica has an oil adsorption rate greater than or equal to about 200 mL / 100 g, about 240 mL / 100 g, or about 250 mL / 100 g.
[0026] 1.5. Any of the preceding compositions wherein the thickening silica is Tixosil 331.
[0027] 1.6. Any of the preceding compositions, wherein the thickening silica is present in an amount of about 1 wt % to about 20 wt %, about 1 wt % to about 10 wt %, about 2 wt % to about 10 wt %, about 4 wt % to about 6 wt %, about 4.5 wt % to about 5.5 wt %, about 4.8 wt % to about 5.2 wt %, or about 5.0 wt %, based on the total weight of the oral care composition.
[0028] 1.7. Any of the preceding compositions, wherein the fluoride ion source is selected from sodium fluoride, stannous fluoride, potassium fluoride, sodium monofluorophosphate, sodium fluorosilicate, ammonium fluorosilicate, amine fluorides (e.g., N'-octadecyltrimethylenediamine-N,N,N'-tris(2-ethanol)-dihydrofluoride), ammonium fluoride, titanium fluoride, hexafluorosulfate, and combinations thereof.
[0029] 1.8. Any of the preceding compositions wherein the fluoride ion source is sodium fluoride.
[0030] 1.9. Any of the preceding compositions wherein the fluoride ion source is present in an amount sufficient to provide 25 ppm to 5000 ppm, typically at least 500 ppm, such as 500 to 2000 ppm, such as 1000 ppm to 1600 ppm, such as 1450 ppm, of fluoride ions.
[0031] 1.10. Any of the preceding compositions, wherein the amount of fluoride adsorbed on the thickening silica is 1% to 20%, e.g., 2% to 20%, 5% to 20%, 10% to 20%, 15% to 20%, 16% to 20%, 17% to 20%, 18% to 20%, or 18% to 19%, by weight of the thickening silica.
[0032] 1.11. Any of the preceding compositions wherein the pH of the composition is 3.5 to 5.5, 3.5 to 5.0, 3.5 to 4.5, 4.0 to 5.5, 4.5 to 5.5, 4.0 to 5.0, 4.0 to 4.5, 3.8 to 4.2, 4.2 to 4.8, 4.2 to 4.6, about 4.0, about 4.1, about 4.2, about 4.3, about 4.4, or about 4.5.
[0033] 1.12. Any of the preceding compositions wherein the fluoride adsorbed on the thickening silica is released at a pH of 8.0.
[0034] 1.13. Any of the preceding compositions, wherein the composition further comprises a thickener other than thickening silica.
[0035] 1.14. Any of the preceding compositions wherein the composition comprises an abrasive.
[0036] 1.15. Any of the foregoing compositions, wherein the abrasive is selected from: a silica abrasive; a calcium phosphate abrasive, such as tricalcium phosphate (Ca3(PO4)2), hydroxyapatite (Ca 10 (PO4)6(OH)2) or calcium hydrogen phosphate dihydrate (CaHPO4·2H2O, sometimes referred to herein as DiCal) or calcium pyrophosphate; calcium carbonate abrasive; or abrasives such as sodium metaphosphate, potassium metaphosphate, aluminum silicate, calcined alumina, bentonite or other siliceous materials; and combinations thereof.
[0037] 1.16. Any of the preceding compositions, wherein the abrasive is selected from calcium phosphate abrasives, such as tricalcium phosphate (Ca3(PO4)2), hydroxyapatite (Ca 10 (PO4)6(OH)2) or calcium hydrogen phosphate dihydrate (CaHPO4.2H2O, sometimes referred to herein as DiCal) or calcium pyrophosphate; calcium carbonate abrasives, and combinations thereof.
[0038] 1.17. Any of the preceding compositions wherein the abrasive is present in an amount of 10% to 70%, e.g., 10% to 30%, e.g., 10% to 20%, 15% to 25%, 20% to 50%, 25% to 45%, or 30% to 40%, by weight of the composition.
[0039] 1.18. Any of the preceding compositions wherein the abrasive comprises a silica abrasive.
[0040] 1.19. Any of the preceding compositions wherein the silica abrasive is present in an amount of 10% to 30%, eg, 10% to 20%, 15% to 25%, or about 15%, by weight of the composition.
[0041] 1.20. Any of the preceding compositions wherein the composition comprises a source of zinc ions.
[0042] 1.21. Any of the preceding compositions wherein the zinc ion source is present in an amount of 0.01% to 5%, eg, 0.1% to 4%, or 0.5% to 3%, by weight of the composition.
[0043] 1.22. Any of the preceding compositions wherein the zinc ion source is selected from the group consisting of zinc oxide, zinc sulfate, zinc chloride, zinc citrate, zinc lactate, zinc gluconate, zinc malate, zinc tartrate, zinc carbonate, zinc phosphate, and combinations thereof.
[0044] 1.23. Any of the preceding compositions wherein the zinc ion source is selected from zinc citrate, zinc oxide, and combinations thereof.
[0045] 1.24. Any of the preceding compositions wherein zinc oxide is present in an amount of 0.5% to 2%, eg, 0.5% to 1.5%, or about 1%, by weight of the composition.
[0046] 1.25. Any of the preceding compositions wherein zinc citrate is present in an amount of 0.1% to 1%, 0.25% to 0.75%, or about 0.5%, by weight of the composition.
[0047] 1.26. Any of the preceding compositions wherein the composition comprises a basic amino acid.
[0048] 1.27. Any of the preceding compositions wherein the basic amino acid comprises one or more of arginine, lysine, citrulline, ornithine, creatine, histidine, diaminobutyric acid, diaminopropionic acid, salts thereof, or combinations thereof.
[0049] 1.28. Any of the preceding compositions wherein the basic amino acid has the L-configuration.
[0050] 1.29. Any of the preceding compositions wherein the basic amino acid is present in an amount of 1% to 15%, e.g., 1% to 10%, 1% to 5%, 1% to 3%, 1% to 2%, 1.2% to 1.8%, 1.4% to 1.6%, or about 1.5%, by weight of the composition, calculated as the free base.
[0051] 1.30. Any of the preceding compositions wherein the basic amino acid comprises arginine.
[0052] 1.31. Any of the preceding compositions wherein the basic amino acid comprises L-arginine.
[0053] 1.32. Any of the preceding compositions wherein the basic amino acid comprises arginine bicarbonate, arginine phosphate, arginine sulfate, arginine hydrochloride, or a combination thereof, optionally wherein the basic amino acid is arginine bicarbonate.
[0054] 1.33. Any of the preceding compositions, wherein the composition comprises a surfactant, e.g., selected from anionic, cationic, zwitterionic and nonionic surfactants, and mixtures thereof, e.g., in an amount of 0.01% to 5%, 0.01% to 2%, 1% to 2%, or about 1.5% by weight of the composition.
[0055] 1.34. Any of the preceding compositions wherein the composition comprises a wetting agent.
[0056] 1.35. Composition 1.34 wherein the humectant comprises glycerin or sorbitol, optionally wherein glycerin or sorbitol is in an amount of 15% to 40%, 20% to 40%, 30% to 40% or about 35% by weight of the composition.
[0057] 1.36. Any of the preceding compositions wherein the composition comprises one or more soluble phosphates, for example selected from tetrasodium pyrophosphate (TSPP), sodium tripolyphosphate (STPP), and combinations thereof.
[0058] 1.37. Any of the preceding compositions wherein the composition comprises a flavoring, aroma, and / or coloring agent.
[0059] 1.38. Any of the foregoing compositions, wherein the composition comprises an effective amount of one or more antimicrobial agents selected from the group consisting of halogenated diphenyl ethers (e.g., triclosan), herbal extracts and essential oils (e.g., rosemary extract, tea extract, magnolia extract, thymol, menthol, eucalyptol, geraniol, carvacrol, citral, honokiol, catechol, methyl salicylate, epigallocatechin gallate, epigallocatechin, gallic acid, miswak extract, sea buckthorn extract), biguanide antimicrobials (e.g., chlorhexidine, alexidine, or octenidine), quaternary ammonium compounds (e.g., cetylpyridinium chloride (CPC), benzalkonium chloride, tetradecylpyridinium chloride (TPC), N-tetradecyl-4-ethylpyridinium chloride (TDEPC), phenolic antimicrobial agents, hexetidine, octenidine, sanguinarine, povidone iodine, delmopinol, salifluor, metal ions (e.g., zinc salts such as zinc citrate, stannous salts, copper salts, iron salts), sanguinarine, propolis and oxidizing agents (e.g., hydrogen peroxide, buffered sodium peroxyborate or sodium percarbonate), phthalic acid and its salts, monoperoxyphthalic acid and its salts and esters, ascorbyl stearate, oleyl sarcosine, alkyl sulfates, dioctyl sulfosuccinate, salicylanilide, domiphen bromide (domiphen bromide), delmopinol, octopirol and other piperidinyl derivatives, nicin preparations, chlorites; and mixtures of any of the foregoing; for example, containing triclosan or cetylpyridinium chloride.
[0060] 1.39. Any of the preceding compositions wherein the composition comprises a whitening agent, eg, selected from the group consisting of peroxides, metal chlorites, perborates, percarbonates, peroxyacids, hypochlorites, and combinations thereof.
[0061] 1.40. Any of the preceding compositions, wherein the composition comprises hydrogen peroxide or a source of hydrogen peroxide, e.g., urea peroxide or a peroxide salt or complex (e.g., a peroxyphosphate, peroxycarbonate, perborate, peroxysilicate, or persulfate; e.g., calcium peroxyphosphate, sodium perborate, sodium carbonate peroxide, sodium peroxyphosphate, and potassium persulfate);
[0062] 1.41. Any of the preceding compositions wherein the composition comprises an agent that will interfere with or prevent bacterial attachment, such as a paraben or chitosan.
[0063] 1.42. Any of the preceding compositions wherein the composition comprises a soluble calcium salt, eg, selected from the group consisting of calcium sulfate, calcium chloride, calcium nitrate, calcium acetate, calcium lactate, and combinations thereof.
[0064] 1.43. Any of the preceding compositions wherein the composition comprises a physiologically or orally acceptable potassium salt, such as potassium nitrate or potassium chloride, in an amount effective to reduce dentin sensitivity.
[0065] 1.44. Any of the preceding compositions wherein the composition comprises a breath freshener, fragrance, or flavoring agent.
[0066] 1.45. Any of the preceding compositions, wherein the composition comprises water, optionally wherein the water is present in an amount of 1% to 80%, 10% to 80%, 20% to 60%, 20% to 40%, 10% to 30%, 20% to 30%, 1% to 20%, 25% to 35%, 1% to 10%, 1% to 5%, or 5% to 10%, by weight of the composition.
[0067] 1.46. Any of the preceding compositions wherein the composition is selected from the group consisting of a toothpaste, a gel, an anhydrous toothpaste, a tooth powder, or a tooth varnish.
[0068] 1.47. Any of the preceding compositions wherein the composition is a toothpaste, a gel or a tooth varnish.
[0069] 1.48. Any of the preceding compositions wherein the composition is a toothpaste.
[0070] 1.49. Any of the preceding compositions, for use to (i) reduce or inhibit the formation of dental caries, (ii) reduce, repair or inhibit pre-caries lesions of tooth enamel, (iii) reduce or inhibit tooth demineralization and promote tooth remineralization, (iv) reduce tooth sensitivity, (v) reduce or inhibit gingivitis, (vi) promote the healing of ulcers or wounds in the oral cavity, (vii) reduce the level of acid-producing bacteria, (viii) reduce or inhibit the formation of microbial biofilms in the oral cavity, (ix) reduce or inhibit the formation of plaque in the oral cavity, (x) promote systemic health or (xi) clean the teeth and oral cavity.
[0071] The oral care composition of the present invention can be in the form of any oral care formulation, including dentifrice, toothpaste, anhydrous toothpaste, gel, mouthwash, powder, cream, strip, chewing gum, beads, film, dental floss, tooth varnish or any other form known in the art. In some embodiments, the oral care composition is a toothpaste or gel. In some embodiments, the oral care composition is a toothpaste.
[0072] The oral care composition of the present invention can be a single-phase oral care composition. For example, all components of the oral care composition can be maintained together with each other in a single phase and / or a single container. For example, all components of the oral care composition can be maintained in a single phase, such as a single homogeneous phase. In another embodiment, the oral care composition can be a multi-phase oral care composition.
[0073] The oral care composition of the present invention may contain an oral acceptable carrier. As used herein, "oral acceptable carrier" refers to a material or material combination that can be safely used in the composition of the present invention and has a reasonable benefit / risk ratio. Such materials include, but are not limited to, for example, water, humectants, ion active ingredients, buffers, anti-tartar agents, grinding and polishing materials, peroxide sources, alkali metal bicarbonates, surfactants, titanium dioxide, colorants, flavor systems, sweeteners, antimicrobial agents, herbal agents, desensitizers, stain reducing agents, and mixtures thereof. Such materials are well known in the art, and those skilled in the art are easy to select them according to the physical and aesthetic properties required for the composition to be prepared. In certain embodiments, an oral acceptable carrier may include an oral acceptable solvent. Illustrative solvents may include, but are not limited to, one or more of the following: ethanol, phenoxyethanol, isopropanol, water, cyclohexane, ethylene glycol monomethyl ether acetate, benzyl alcohol, etc., or any mixture or combination thereof. In a specific embodiment, an oral acceptable solvent includes benzyl alcohol.
[0074] In some embodiments, water may be present in the oral composition of the present invention. The water used in the preparation of commercial oral compositions should be deionized and free of organic impurities. Water generally constitutes the remainder of the composition and constitutes 1% to 80%, 10% to 80%, 20% to 60%, 20% to 40%, 10% to 30%, 20% to 30%, 1% to 20%, 25% to 35%, 1% to 10%, 1% to 5%, or 5% to 10% of the weight of the oral composition. This amount of water includes the free water added plus the amount introduced with other materials such as sorbitol or any component of the present invention. In other embodiments, the composition may be substantially free of water, for example, the composition may contain less than 1%, less than 0.1% or less than 0.01% of the amount of water. In some embodiments, the composition is free of water. In certain embodiments, the composition is anhydrous toothpaste.
[0075] The oral care composition of the present invention comprises a particle size distribution (D95) of less than or equal to 7 μm and a particle size distribution (D95) of greater than or equal to 150 μm. 2 / g of BET surface area of thickening silica, and a fluoride ion source. In the composition of the present invention, wherein the pH of the composition is lower than 5.5, fluoride is adsorbed onto the thickening agent. As used herein, the terms "adsorption" and "loading" mean that fluoride (fluoride ions) are bound to thickening silica so that the fluoride cannot move freely. In some embodiments, the amount of fluoride adsorbed on the thickening silica is 1% to 20% of the weight of the thickening silica, for example 2% to 20%, 5% to 20%, 10% to 20%, 15% to 20%, 16% to 20%, 17% to 20%, 18% to 20%, or 18% to 19%. The fluoride adsorbed on the thickening silica is released at a pH of 8.0. In the context of the present invention, the particle size distribution (e.g. D95) can be determined, for example, by using a volumetric dynamic laser light scattering method, preferably using an instrument from Malvern Instruments, Ltd., Malvern, UK, preferably a Mastersizer 2000. Additionally, in the context of the present invention, BET surface area measurements can be performed, for example, according to the ISO 9277:2010 (E) standard, using nitrogen and, for example, a static volumetric method and a multipoint method.
[0076] The thickening silica present in the oral care composition of the present invention has a particle size distribution (D95) of less than or equal to 7 μm and a particle size distribution (D95) of greater than or equal to 150 μm. 2 In some embodiments, the thickening silica may have a BET surface area greater than or equal to 175 m 2 / g, greater than or equal to 200m 2 / g, or greater than or equal to 250m 2 / g BET surface area. In some embodiments, the thickening silica may have an oil adsorption rate greater than or equal to about 200 mL / 100 g, about 240 mL / 100 g, or about 250 mL / 100 g. In some embodiments, the thickening silica may have an average particle size of about 3 μm to about 5 μm, about 3 μm to about 4 μm, or about 3.5 μm. In a preferred embodiment, the thickening silica is Tixosil 331 commercially available from Solvay (Brussels, Belgium).
[0077] In some embodiments, the thickening silica can be present in an amount of about 1 wt % to about 20 wt %, e.g., about 1 wt % to about 10 wt %, about 2 wt % to about 10 wt %, about 4 wt % to about 6 wt %, about 4.5 wt % to about 5.5 wt %, about 4.8 wt % to about 5.2 wt %, or about 5.0 wt %, based on the total weight of the oral care composition.
[0078] The oral care composition of the present invention includes fluoride, such as one or more fluoride ion sources (such as soluble fluoride salts). A variety of materials for producing fluoride ions can be used as the source of soluble fluoride. Illustrative fluoride ion sources include but are not limited to sodium fluoride, stannous fluoride, potassium fluoride, sodium monofluorophosphate, fluorosilicates such as sodium fluorosilicate and ammonium fluorosilicate, amine fluoride, ammonium fluoride and combinations thereof. In certain embodiments, the fluoride ion source includes sodium fluoride. The amount of the fluoride ion source in the oral care composition can be greater than 0 wt % and less than 0.8 wt %, less than 0.7 wt %, less than 0.6 wt %, less than 0.5 wt % or less than 0.4 wt %. The amount of the fluoride ion source is enough to provide 25 ppm to 5,000 ppm, usually at least 500 ppm, such as 500 to 2000 ppm, such as 1000 ppm to 1600 ppm, such as 1450 ppm of fluoride ions.
[0079] In some embodiments, the pH of the oral care compositions of the present invention can be 3.5 to 5.5, 3.5 to 5.0, 3.5 to 4.5, 4.0 to 5.5, 4.5 to 5.5, 4.0 to 5.0, 4.0 to 4.5, 3.8 to 4.2, 4.2 to 4.8, 4.2 to 4.6, about 4.0, about 4.1, about 4.2, about 4.3, about 4.4, or about 4.5.
[0080] The oral care compositions of the present invention may include one or more pH adjusting agents. For example, the oral care compositions may include one or more acidulants and / or one or more alkalizing agents configured to respectively reduce and / or increase their pH. Illustrative acidulants and / or one or more alkalizing agents may be or include, but are not limited to, alkali metal hydroxides such as sodium hydroxide and / or potassium hydroxide, citric acid, hydrochloric acid, etc., or combinations thereof.
[0081] The oral care composition of the present invention may also include one or more buffers configured to control or adjust pH within a predetermined or desired range. Illustrative buffers may include, but are not limited to, sodium bicarbonate, sodium phosphate, sodium carbonate, sodium acid pyrophosphate, sodium citrate, and mixtures thereof. Sodium phosphate may include monosodium phosphate (NaH2PO4), disodium phosphate (Na2HPO4), trisodium phosphate (Na3PO4), and mixtures thereof. In a typical embodiment, the buffer may be anhydrous disodium hydrogen phosphate or disodium phosphate and / or sodium dihydrogen phosphate. In another embodiment, the buffer includes anhydrous disodium hydrogen phosphate or disodium phosphate and phosphoric acid (e.g., syrupy phosphoric acid; 85%-food grade).
[0082] The oral care composition of the present invention may include free or salt-form basic amino acids. The basic amino acids that can be used in the composition include not only naturally occurring basic amino acids such as arginine, lysine and histidine, but also any basic amino acids with carboxyl groups and amino groups in the molecule, the basic amino acids being water-soluble and providing an aqueous solution with a pH of about 7 or higher. Accordingly, basic amino acids include but are not limited to arginine, lysine, citrulline, ornithine, creatine, histidine, diaminobutyric acid, diaminopropionic acid, its salt or a combination thereof. In a specific embodiment, the basic amino acids are selected from arginine, lysine, citrulline and ornithine. Basic amino acids can generally exist in L-form or L-configuration. Basic amino acids can be provided as salts of dipeptides or tripeptides comprising amino acids. In certain embodiments, at least a portion of the basic amino acids present in the oral care composition is in salt form. In certain embodiments, the basic amino acid is arginine, such as L-arginine, or a salt thereof. Arginine can be provided as free arginine or a salt thereof. For example, arginine can be provided in the form of arginine phosphate, arginine hydrochloride, arginine sulfate, arginine bicarbonate, etc., and mixtures or combinations thereof. The basic amino acid can be provided in solution or solid form. For example, the basic amino acid can be provided in the form of an aqueous solution. In some embodiments, the amino acid comprises an arginine bicarbonate solution or is provided by an arginine bicarbonate solution. For example, the amino acid can be provided by a basic amino acid, such as about 40% solution of arginine bicarbonate (or arginine carbamate). In some embodiments, the basic amino acid is present in an amount of 1% to 15%, for example 1% to 10%, 1% to 5%, 1% to 3%, 1% to 2%, 1.2% to 1.8%, 1.4% to 1.6%, or about 1.5% by weight of the composition, calculated as a free base.
[0083] The oral care composition of the present invention may include a zinc ion source. The zinc ion source may be or may include zinc ions and / or one or more zinc salts. For example, a zinc salt may at least partially dissociate in an aqueous solution to produce zinc ions. Illustrative zinc salts may include, but are not limited to, zinc lactate, zinc oxide, zinc chloride, zinc phosphate, zinc citrate, zinc acetate, zinc borate, zinc butyrate, zinc carbonate, zinc formate, zinc gluconate, zinc glycerate, zinc glycolate, zinc picolinate, zinc propionate, zinc salicylate, zinc silicate, zinc stearate, zinc tartrate, zinc undecylenate, and mixtures thereof. In some embodiments, the zinc ion source is 0.01% to 5%, for example 0.1% to 4%, or 1% to 3% of the composition weight.
[0084] In some embodiments, the zinc ion source is selected from zinc oxide, zinc citrate and combinations thereof. Zinc oxide can be present in an amount of 0.5% to 2%, for example 0.5% to 1.5% or about 1%, by weight of the composition. Zinc citrate can be present in an amount of 0.1% to 1%, 0.25% to 0.75%, about 0.5%, by weight of the composition. In some embodiments, the composition comprises zinc oxide and zinc citrate. The composition may comprise zinc oxide in an amount of 0.5% to 2%, for example 0.5% to 1.5%, about 1% or about 1.2%, by weight of the composition and zinc citrate in an amount of 0.1% to 1%, 0.25% to 0.75%, about 0.5%, by weight of the composition. In certain embodiments, the composition comprises zinc oxide in an amount of about 1%, by weight of the composition and zinc citrate in an amount of about 0.5%, by weight of the composition.
[0085] The oral care composition of the present invention may include at least one surfactant or solubilizer. Suitable surfactants include neutral surfactants (such as polyoxyethylene hydrogenated castor oil or fatty acids of sugars), anionic surfactants (such as sodium lauryl sulfate), cationic surfactants (such as ammonium cationic surfactants) or zwitterionic surfactants. These surfactants or solubilizers may generally be present in an amount of 0.01% to 5%, 0.01% to 2%, or 1% to 2%, or about 1.5% by weight of the composition. In some embodiments, the composition may include sodium lauryl sulfate. In some embodiments, the composition may include betaine zwitterionic surfactants and nonionic block copolymers. Betaine zwitterionic surfactants may be C8-C 16Aminopropyl betaine, such as cocamidopropyl betaine. In some embodiments, betaine zwitterionic surfactants, such as cocamidopropyl betaine, are present in an amount of 1% to 1.5%, 1.1% to 1.4%, 1.2% to 1.3% or about 1.25% by weight of the composition. The nonionic block copolymer can be a poly(propylene oxide) / poly(ethylene oxide) copolymer. In some embodiments, the copolymer has a polyoxypropylene molecular weight of 3000 to 5000 g / mol and a polyoxyethylene content of 60 to 80 mol%. In some embodiments, the nonionic block copolymer is a poloxamer. In some embodiments, the nonionic block copolymer is selected from: poloxamer 338, poloxamer 407, poloxamer 237, poloxamer 217, poloxamer 124, poloxamer 184, poloxamer 185 and a combination of two or more thereof. In some embodiments, the copolymer is poloxamer 407, which is commercially available as Pluronic F-127 (Pluronic is a trademark of BASF Corporation). In some embodiments, the nonionic block copolymer, e.g., a poloxamer, e.g., poloxamer 407, is present in an amount of 0.3% to 0.7%, 0.4% to 0.6%, or about 0.5% by weight of the composition.
[0086] The oral care composition of the present invention may include a thickener other than thickening silica having a particle size distribution (D95) of less than or equal to 7 μm and a particle size distribution (D95) of greater than or equal to 150 μm. 2 / g of BET surface area. Other suitable thickeners can be any orally acceptable thickener or thickening agent configured to control the viscosity of the oral care composition. Illustrative thickeners can be or include, but are not limited to, cross-linked polyvinyl pyrrolidone (PVP) polymers, cross-linked polyvinyl pyrrolidone (PVP), etc., or mixtures or combinations thereof. In some embodiments, the thickening system includes a cross-linked polyvinyl pyrrolidone (PVP) polymer. The thickening system can also include commercially available from Ashland Inc. of Covington, KY. XL 10F. Exemplary thickeners may also be or may include, but are not limited to, carbomers (e.g., carboxyvinyl polymers), carrageenans (e.g., Irish moss, carrageenan, iota-carrageenan, etc.), high molecular weight polyethylene glycols (e.g., which are commercially available from Dow Chemical Company (Midland, Michigan), cellulose polymers, hydroxyethyl cellulose, carboxymethyl cellulose and its salts (e.g., sodium CMC), natural gums (e.g., gum karaya, xanthan gum, gum arabic and gum tragacanth), colloidal magnesium aluminum silicate, and the like, or mixtures or combinations thereof. Thickeners particularly suitable for use in the oral care compositions of the present invention include natural and synthetic gums and colloids. Optionally, the composition comprises at least one gum selected from carrageenan and xanthan gum.
[0087] In some embodiments, the oral care composition may include one or more abrasives or an abrasive system including one or more abrasives. As used herein, the term "abrasive" may also refer to materials commonly referred to as "polishing agents." Any orally acceptable abrasive may be used, but preferably, the type, fineness (particle size), and amount of the abrasive may be selected so that tooth enamel is not excessively abraded during normal use of the oral care composition.
[0088] One or more abrasives may have a particle size or D50 of less than or equal to about 10 μm, less than or equal to about 8 μm, less than or equal to about 5 μm, or less than or equal to about 3 μm. One or more abrasives may have a particle size or D50 of greater than or equal to about 0.01 μm, greater than or equal to about 0.05 μm, greater than or equal to about 0.1 μm, greater than or equal to about 0.5 μm, or greater than or equal to about 1 μm. Illustrative abrasives may include, but are not limited to, metaphosphate compounds, phosphates (e.g., insoluble phosphates) such as sodium metaphosphate, potassium metaphosphate, calcium pyrophosphate, magnesium orthophosphate, trimagnesium orthophosphate, tricalcium phosphate, dicalcium phosphate dihydrate, anhydrous dicalcium phosphate, calcium carbonate (e.g., precipitated calcium carbonate and / or natural calcium carbonate), magnesium carbonate, hydrated alumina, silica, zirconium silicate, aluminum silicate including calcined aluminum silicate, polymethyl methacrylate, etc., or mixtures thereof and combinations thereof. In some embodiments, the oral care composition comprises abrasive silica.
[0089] In some embodiments, the oral care composition of the present invention comprises a calcium-containing abrasive (e.g., calcium carbonate). In some embodiments, the calcium-containing abrasive is selected from calcium carbonate, calcium phosphate (e.g., dicalcium phosphate dihydrate), calcium sulfate, and combinations thereof. In a preferred embodiment, the oral care composition comprises calcium carbonate as an abrasive. In one embodiment, the oral care composition comprises precipitated calcium carbonate or natural calcium carbonate. Precipitated calcium carbonate may be superior to natural calcium carbonate.
[0090] The amount or concentration of one or more abrasives present in the oral care composition can vary widely. In some embodiments, the amount of abrasive present in the oral care composition can be from about 15% to about 70% by weight, such as from about 20% to about 50% by weight, from about 25% to about 45% by weight, from about 30% to about 40% by weight, from about 10% to about 20% by weight, or about 15% by weight, based on the total weight of the oral care composition.
[0091] In some embodiments, the oral care composition of the present invention may include one or more wetting agents. Wetting agents can reduce evaporation and also help preserve by reducing water activity, and can also give the composition desired sweetness or flavor. Schematic wetting agents can be or can include but are not limited to glycerol, propylene glycol, polyethylene glycol, sorbitol, xylitol, etc. or any mixture or combination thereof. In some embodiments, the composition comprises a wetting agent selected from glycerol, sorbitol and a mixture thereof. In some embodiments, by the weight of the composition, the wetting agent can be present in an amount of 20% to 60%, for example 15% to 40%, 15% to 35%, 20% to 40%, 30% to 50%, 30% to 40%, or 40% to 45%. In some embodiments, the composition comprises glycerol or sorbitol, optionally, wherein glycerol or sorbitol is present in an amount of 15% to 40%, 20% to 40%, 30% to 40% or about 35% by weight of the composition.
[0092] The oral care composition of the present invention may contain a preservative. Suitable preservatives include, but are not limited to, sodium benzoate, potassium sorbate, methylisothiazolinone, paraben preservatives such as methylparaben, propylparaben, and mixtures thereof.
[0093] The oral care composition of the present invention may include a sweetener, such as saccharin, such as sodium saccharin, acesulfame, neotame, sodium cyclamate or sucralose; a natural high intensity sweetener such as thaumatin, stevioside or glycyrrhizin; or such as sorbitol, xylitol, maltitol or mannitol. One or more such sweeteners may be 0.005% to 5%, such as 0.01% to 1%, such as 0.01% to 0.5% by weight of the composition.
[0094] The oral care compositions of the present invention may include flavoring agents. Suitable flavoring agents include, but are not limited to, essential oils and various flavored aldehydes, esters, alcohols and similar substances, as well as sweeteners such as saccharin sodium. Examples of essential oils include oils of spearmint, peppermint, holly, sassafras, cloves, sage, eucalyptus, marjoram, cinnamon, lemon, lime, grapefruit and orange. Chemicals such as menthol, carvone and anethole are also available. Flavoring agents are typically incorporated into the oral composition at a concentration of 0.01% to 3% by weight.
[0095] The oral care composition of the present invention may include an anticalculus agent. Illustrative anticalculus agents may include, but are not limited to, phosphates and polyphosphates (e.g., pyrophosphates), polyaminopropanesulfonic acid (AMPS), hexametaphosphate, zinc citrate trihydrate, polypeptides, polyolefin sulfonates, polyolefin phosphates, bisphosphonates. In some embodiments, the anticalculus agent includes tetrasodium pyrophosphate (TSPP), sodium tripolyphosphate (STPP), or a combination thereof.
[0096] The oral care composition of the present invention may include an antioxidant. Any orally acceptable antioxidant may be used, including but not limited to butylated hydroxyanisole (BHA), butylated hydroxytoluene (BHT), vitamin A, carotenoids, vitamin E, flavonoids, polyphenols, ascorbic acid, herbal antioxidants, chlorophyll, melatonin, etc., or combinations and mixtures thereof.
[0097] The oral care composition of the present invention may include one or more pigments, such as whitening pigments. In certain embodiments, whitening pigments include particles having a size of about 0.1 μm to about 10 μm and a refractive index greater than about 1.2. Suitable whitening agents include, but are not limited to, titanium dioxide particles, zinc oxide particles, aluminum oxide particles, tin oxide particles, calcium oxide particles, magnesium oxide particles, barium oxide particles, silicon dioxide particles, zirconium silicate particles, mica particles, talcum particles, tetracalcium phosphate particles, amorphous calcium phosphate particles, α-tricalcium phosphate particles, β-tricalcium phosphate particles, hydroxyapatite particles, calcium carbonate particles, zinc phosphate particles, silicon dioxide particles, zirconium silicate particles, etc., or mixtures and combinations thereof. Whitening pigments such as titanium dioxide particles can be present in an amount sufficient to whiten teeth.
[0098] All ingredients used in the compositions described herein should be orally acceptable. As used herein, "orally acceptable" can refer to any ingredient present in the composition as described in an amount and form that does not render the composition unsafe for use in the oral cavity.
[0099] In another aspect, the present invention provides a method to (i) reduce or inhibit the formation of caries, (ii) reduce, repair or inhibit pre-caries lesions of tooth enamel, (iii) reduce or inhibit tooth demineralization and promote tooth remineralization, (iv) reduce tooth sensitivity, (v) reduce or inhibit gingivitis, (vi) promote the healing of ulcers or wounds in the mouth, (vii) reduce the level of acid-producing bacteria, (viii) reduce or inhibit the formation of microbial biofilms in the mouth, (ix) reduce or inhibit the formation of plaque in the mouth, (x) promote systemic health or (xi) clean teeth and the mouth, the method comprising applying an effective amount of any oral care composition as disclosed herein to the oral cavity of a subject in need thereof. The method may include contacting the oral care composition with water. The method may also include contacting the tooth surface with the oral care composition. Contacting the tooth surface with the oral care composition may include placing the oral care composition (e.g., toothpaste) on a toothbrush and brushing the teeth with the toothbrush. The oral care composition may be applied and / or contacted with the surface of the tooth at predetermined time intervals. For example, once a day, at least once a day, twice a day or more, for multiple days, or once every other day. In another example, the oral care composition can be applied and / or contacted with the tooth surface at least once a day, at least once every two days, at least once every three days, at least once every five days, at least once a week, at least once every two weeks, or at least once a month. The oral care composition can be used for up to 2 weeks, up to 3 weeks, up to 4 weeks, up to 6 weeks, up to 8 weeks, or longer.
[0100] In another aspect, the present invention provides any oral care composition as disclosed herein for use in a subject in need thereof to (i) reduce or inhibit the formation of dental caries, (ii) reduce, repair or inhibit pre-caries lesions of tooth enamel, (iii) reduce or inhibit tooth demineralization and promote tooth remineralization, (iv) reduce tooth sensitivity, (v) reduce or inhibit gingivitis, (vi) promote the healing of ulcers or wounds in the oral cavity, (vii) reduce the level of acid-producing bacteria, (viii) reduce or inhibit the formation of microbial biofilms in the oral cavity, (ix) reduce or inhibit the formation of plaque in the oral cavity, (x) promote systemic health, or (xi) clean the teeth and oral cavity.
[0101] In another aspect, the present invention provides a method for preparing a fluoride-loaded thickening silica, comprising mixing a thickening silica and a fluoride ion source in an aqueous solution (e.g., water) at a pH below 5.5, e.g., 3.5 to 5.5, 3.5 to 5.0, 3.5 to 4.5, 4.0 to 5.0, 4.0 to 4.5, 3.5 to 4.0, 3.8 to 4.2, or about 4.0, wherein the thickening silica has a particle size distribution (D95) of less than or equal to 7 μm and a particle size distribution (D95) of greater than or equal to 150 μm. 2In some embodiments, the thickening silica may have a BET surface area greater than or equal to 175 m 2 / g, greater than or equal to 200m 2 / g, or greater than or equal to 250m 2 / g of BET surface area. In some embodiments, the thickening silica may have an oil adsorption rate greater than or equal to about 200 mL / 100 g, about 240 mL / 100 g, or about 250 mL / 100 g. In some embodiments, the thickening silica may have an average particle size of about 3 μm to about 5 μm, about 3 μm to about 4 μm, or about 3.5 μm. In a preferred embodiment, the thickening silica is Tixosil 331. A variety of materials that produce fluoride ions can be used as a source of soluble fluoride. Illustrative fluoride ion sources include but are not limited to sodium fluoride, stannous fluoride, potassium fluoride, sodium monofluorophosphate, fluorosilicates such as sodium fluorosilicate and ammonium fluorosilicate, amine fluoride, ammonium fluoride, and combinations thereof. In a preferred embodiment, the fluoride ion source includes sodium fluoride.
[0102] In another aspect, the present invention provides an oral care composition comprising a thickening silica loaded with fluoride prepared by any of the methods disclosed herein. The fluoride adsorbed on the thickening silica is released at a pH of 8.0.
[0103] Examples
[0104] Fluoride-loaded thickening silica (also called silica fluoride) was prepared as follows. A 10000 ppm fluoride solution was prepared by dissolving 2.2 g of sodium fluoride in water, followed by pH adjustment to pH = 4.0 with HCl. 5 g of thickening silica (Tixosil 331 from Solvay) were suspended in the fluoride solution. Under this condition, 0.93 g of the 1.00 g of fluoride initially dissolved in the solution were bound to the silica to produce a fluorine loading on the silica corresponding to 18.6%.
[0105] The release of fluoride from silica fluoride was measured by increasing the pH of the silica fluoride solution to 8.5. Figure 1 The fluoride is completely released from the silica fluoride above pH 7.5, indicating that the adsorption process can be easily reversed by changing the pH to about 8. This is a very interesting range to work in, as it allows the formulation of oral care formulations with a low Ph, around 4.5, where most of the fluoride is adsorbed onto the silica. During use, the fluoride is released in the mouth after the physiological pH of the oral cavity has reached equilibrium, around 7 to 8.
[0106] Next, the kinetics of fluoride release from silica fluoride after pH change was determined at room temperature (24.0°C). In this experiment, the released fluoride was measured over time until 478 seconds after the pH was changed from 4 to 8 in one step. The results are in Figure 2 Fluoride was released slowly from silica and reached a plateau in about 400 seconds, which is 3-4 times longer than normal brushing time. This result suggests that the release is slow enough to allow silica to reach and adhere to the dentin.
[0107] The present disclosure has been described with reference to exemplary embodiments. Although a limited number of embodiments have been shown and described, it will be appreciated by those skilled in the art that changes may be made in these embodiments without departing from the principles and spirit of the previous specific embodiments. The present disclosure is intended to be interpreted as including all such modifications and changes as long as they fall within the scope of the appended claims or their equivalents.
Claims
1. An oral care composition comprising an orally acceptable carrier, thickening silica, and a fluoride ion source, wherein fluoride is adsorbed onto the thickening silica, wherein the thickening silica has a D95 particle size distribution of less than or equal to 7 μm and a particle size distribution of greater than or equal to 150 μm. 2 / g of BET surface area, and wherein the pH of the composition is equal to or lower than 5.5, wherein the fluoride-loaded thickening silica is prepared by mixing the thickening silica and the fluoride ion source in an aqueous solution at a pH equal to or lower than 5.5, wherein the fluoride ion source is selected from the group consisting of sodium fluoride, stannous fluoride, potassium fluoride, sodium monofluorophosphate, amine fluoride, ammonium fluoride, and combinations thereof, wherein the thickening silica is present in an amount of 1% to 20% by weight of the composition, wherein the amount of fluoride adsorbed on the thickening silica is 1% to 20% by weight of the thickening silica, and wherein the release of fluoride reaches a plateau at 400 seconds when measured at 24°C.
2. The composition according to claim 1, wherein the thickening silica has a thickness greater than or equal to 175 m 2 / g of BET surface area.
3. The composition according to claim 2, wherein the thickening silica has a thickness greater than or equal to 200 m 2 / g of BET surface area.
4. The composition according to claim 2, wherein the thickening silica has a thickness greater than or equal to 250 m 2 / g of BET surface area. 5 . The composition according to claim 1 , wherein the thickening silica has an average particle size of 3 to 5 μm. The composition according to claim 5 , wherein the average particle size of the thickening silica is 3 to 4 μm.
7. The composition according to any one of claims 1 to 4, wherein the thickening silica has an oil adsorption rate greater than or equal to 200 mL / 100 g.
8. The composition according to claim 7, wherein the thickening silica has an oil adsorption rate greater than or equal to 240 mL / 100 g.
9. The composition according to claim 7, wherein the thickening silica has an oil adsorption rate greater than or equal to 250 mL / 100 g.
10. The composition of any one of claims 1 to 4, wherein the fluoride ion source is sodium fluoride.
11. The composition of any one of claims 1 to 4, wherein the fluoride ion source is present in an amount sufficient to provide 25 ppm to 5000 ppm of fluoride ions.
12. The composition of any one of claims 1 to 4, wherein the pH of the composition is from 3.5 to 5.
5.
13. The composition according to any one of claims 1 to 4, wherein the fluoride adsorbed on the thickening silica is released at a pH of 8.
0.
14. The composition according to any one of claims 1 to 4, wherein the composition is selected from toothpaste, gel, tooth powder and tooth varnish.
15. The composition of claim 14, wherein the composition is an anhydrous toothpaste.
